Meeting details menu

Meeting Authors
Meeting Abstracts
Keynote lectures
Oral communications
Poster presentations
Special symposia
Other

Acta Physiologica Congress

Back

Acta Physiologica 2006; Volume 186, Supplement 650
Joint Meeting of The German Society of Physiology and The Federation of European Physiological Societies 2006
3/26/2006-3/29/2006
Ludwig-Maximilians-University, Munich


RUN-DOWN OF GABAA-RECEPTORS IN THE HUMAN EPILEPTIC BRAIN
Abstract number: PT01A-9

Palma1 E, Ragozzino1 D, Di Angelantonio1 S, Amici1 M, Eusebi1 F

1University of Rome La Sapienza, Dpt. of Human Physiology and Pharmacology, Neuromed, I.R.C.S.S.

Cell membranes isolated from the temporal neocortex of patients afflicted with drug-resistant mesial temporal lobe epilepsy (TLE) are injected into frog oocytes. Within few hours the oocytes acquire functional g-aminobutyric acid type A receptors (GABAAR) and the GABA evoked currents display marked run-down during repetitive applications of the neurotransmitter. In contrast, GABAAR function is stable upon repetitive applications of GABA in oocytes injected with cell membranes isolated from the temporal lobe of TLE patients afflicted with neoplastic, dysgenetic, traumatic or ischemic temporal lesions (lesional TLE, LTLE). It was found that this use-dependent GABAAR run-down develops also in pyramidal neurons of TL neocortical slices, while TL pyramidal neurons from neocortical slices of a traumatic LTLE patient do not show GABAAR run-down. Preliminary results in oocytes expressing "epileptic" GABAA receptors show that the run-down could be reduced by endocytosis inhibitors, concanavalin-A and primaquine. We speculate that the use-dependent functional instability of neocortical GABAAR represents a TLE-specific dysfunction and is due to an increase of receptor endocytosis.

To cite this abstract, please use the following information:
Acta Physiologica 2006; Volume 186, Supplement 650 :PT01A-9

Our site uses cookies to improve your experience.You can find out more about our use of cookies in our standard cookie policy, including instructions on how to reject and delete cookies if you wish to do so.

By continuing to browse this site you agree to us using cookies as described in our standard cookie policy .

CLOSE